1
Paul Edward Aldrich, Argyrios Georgios Arvanitis, Robert Scott Cheeseman, Robert John Chorvat, Thomas Eugene Christos, Paul Joseph Gilligan, Dimitri Emil Grigoriadis, Carl Nicholas Hodge, Paul John Krenitsky, Everett Latham Scholfield, Sang William Tam, Zelda Rakowitz Wasserman: 1N-alkyl-n-arylpyrimidinamines and derivatives thereof. DuPont Pharmaceuticals Company, Robert W Black, Kenneth B Rubin, Kalim S Fuzail, January 29, 2002: US06342503 (65 worldwide citation)

The present invention provides novel compounds, compounds and pharmaceutical compositions thereof, and methods of using same in the treatment of affective disorders, anxiety, depression, post-traumatic stress disorders, eating disorders, supranuclear palsy, irritable bowel syndrome, immune suppressi ...


2
Paul Edward Aldrich, Argyrios Georgios Arvanitis, Rajagopal Bakthavatchalam, James Peter Beck, Robert Scott Cheeseman, Robert John Chorvat, Paul Joseph Gilligan, Carl Nicholas Hodge, Zelda Rakowitz Wasserman: 1N-alkyl-N-arylpyrimidinamines and derivatives thereof. Dupont Pharmaceuticals Company, Monte R Browder, Kenneth B Rubin, August 22, 2000: US06107301 (58 worldwide citation)

The present invention provides novel compounds, compounds and pharmaceutical compositions thereof, and methods of using same in the treatment of affective disorders, anxiety, depression, post-traumatic stress disorders, eating disorders, supranuclear palsy, irritable bowel syndrome, immune suppressi ...


3
P E Aldrich, A G Arvannitis, R S Cheeseman: 1n-alkyl-n-arylpyrimidinamines and derivatives thereof. The Du Pont Merck Pharmaceutical Co, WU YUHE TIAN MINGSHENG, February 12, 1997: CN94194465

The present invention provides novel compounds, compounds and pharmaceutical compositions thereof, and methods of using same in the treatment of affective disorders, anxiety, depression, post-traumatic stress disorders, eating disorders, supranuclear palsy, irritable bowel syndrome, immune suppressi ...


4
Aldrich Paul Edward, Arvanitis Argyrios Georgios, Cheeseman Robert Scott, Chorvat Robert John, Christos Thomas Eugene, Gilligan Paul Joseph, Grigoriadis Dimitri Emil, Hodge Carl Nicholas, Krenitsky Paul John, Scholfield Everett Latham, Tam Sang William, Wasserman Zelda Rakowitz: 1n-alkyl-n-arylpyrimidinamines and derivatives thereof. The Du Pont Merck Pharmaceutical Company, BOUDREAUX Gerald J, April 20, 1995: WO/1995/010506

The present invention provides novel compounds, compounds and pharmaceutical compositions thereof, and methods of using same in the treatment of affective disorders, anxiety, depression, post-traumatic stress disorders, eating disorders, supranuclear palsy, irritable bowel syndrome, immune suppressi ...


5
Aldrich Paul Edward, Arvanitis Argyrios Georgios, Cheeseman Robert Scott, Chorvat Robert John, Christos Thomas Eugene, Gilligan Paul Joseph, Grigoriadis Dimitri Emil, Hodge Carl Nicholas, Krenitsky Paul J, Scholfield Everett Latham, Tam Sang William, Wasserman Zelda Rakowitz: 1n-alkyl-n-arylpyrimidinamines and derivatives thereof. Du Pont Merck Pharma, July 31, 1996: EP0723533-A1

The present invention provides novel compounds, compounds and pharmaceutical compositions thereof, and methods of using same in the treatment of affective disorders, anxiety, depression, post-traumatic stress disorders, eating disorders, supranuclear palsy, irritable bowel syndrome, immune suppressi ...



Click the thumbnails below to visualize the patent trend.